DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer

Recently, a set of studies addressed the question of the prevalence of aberrant methylation in surrogate tissues, such as peripheral blood leukocytes. Toward this aim, we conducted a case-control pilot study to investigate aberrant methylation in leukocytes of gastric cancer patients. The SNuPE comb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anticancer research 2014-10, Vol.34 (10), p.5381-5388
Hauptverfasser: Dauksa, Albertas, Gulbinas, Antanas, Endzinas, Zilvinas, Oldenburg, Johannes, El-Maarri, Osman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5388
container_issue 10
container_start_page 5381
container_title Anticancer research
container_volume 34
creator Dauksa, Albertas
Gulbinas, Antanas
Endzinas, Zilvinas
Oldenburg, Johannes
El-Maarri, Osman
description Recently, a set of studies addressed the question of the prevalence of aberrant methylation in surrogate tissues, such as peripheral blood leukocytes. Toward this aim, we conducted a case-control pilot study to investigate aberrant methylation in leukocytes of gastric cancer patients. The SNuPE combined with ion pair reverse phase HPLC (SIRPH method) was used to examine site-specific methylation status at selected CpG sites of the promoter regions of APC, ACIN1, BCL2, CD44, DAPK1, CDKN2A, RARB, TNFRSF10C HS3ST2 and of LINE-1, Alu repeats. We observed that in the patients, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while DNA repetitive elements were slightly less methylated compared to controls. This was found to be significantly associated with higher prevalence for gastric cancer. These results suggest that larger studies must be carried-out to explore the biological significance and clinical usefulness of leukocyte DNA as non-invasive detection tool for gastric cancer.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1773826723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1773826723</sourcerecordid><originalsourceid>FETCH-LOGICAL-p244t-db41e4bde76d5c3a681a040a046ee986b1a1f701bd1c445a7ff4e9f71f2f8da23</originalsourceid><addsrcrecordid>eNqFkL1OwzAYRS0EoqXwCsgjSyT_OxmrAgWpggXmyLE_U4PTBNtB6ttTQZkZrs5wj-5wT9Cc6oZWWnJyiuaESVJpQuQMXeT8TohSTc3P0YxJpiXhbI7c7dMS91C2-2hKGHbYFJwhgi3g8Gpc4xwKZBx2eIQUxi0kE3EXh8HhCNPHYPc_dcZjAhdsCV-AB4_fTC4pWGzNzkK6RGfexAxXRy7Q6_3dy-qh2jyvH1fLTTUyIUrlOkFBdA60ctJyo2pqiCCHKICmVh011GtCO0etENJo7wU0XlPPfO0M4wt087s7puFzglzaPmQLMZodDFNuqda8Zkoz_r8qa0WaRnF5UK-P6tT14Noxhd6kfft3Iv8G711vYw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1586099635</pqid></control><display><type>article</type><title>DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Dauksa, Albertas ; Gulbinas, Antanas ; Endzinas, Zilvinas ; Oldenburg, Johannes ; El-Maarri, Osman</creator><creatorcontrib>Dauksa, Albertas ; Gulbinas, Antanas ; Endzinas, Zilvinas ; Oldenburg, Johannes ; El-Maarri, Osman</creatorcontrib><description>Recently, a set of studies addressed the question of the prevalence of aberrant methylation in surrogate tissues, such as peripheral blood leukocytes. Toward this aim, we conducted a case-control pilot study to investigate aberrant methylation in leukocytes of gastric cancer patients. The SNuPE combined with ion pair reverse phase HPLC (SIRPH method) was used to examine site-specific methylation status at selected CpG sites of the promoter regions of APC, ACIN1, BCL2, CD44, DAPK1, CDKN2A, RARB, TNFRSF10C HS3ST2 and of LINE-1, Alu repeats. We observed that in the patients, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while DNA repetitive elements were slightly less methylated compared to controls. This was found to be significantly associated with higher prevalence for gastric cancer. These results suggest that larger studies must be carried-out to explore the biological significance and clinical usefulness of leukocyte DNA as non-invasive detection tool for gastric cancer.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>PMID: 25275032</identifier><language>eng</language><publisher>Greece</publisher><subject>Aged ; Aged, 80 and over ; Case-Control Studies ; Cluster Analysis ; CpG Islands ; DNA Methylation ; Epigenesis, Genetic ; Epigenomics ; Female ; Gene Expression Profiling ; Humans ; Leukocytes - metabolism ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Staging ; Prevalence ; Repetitive Sequences, Nucleic Acid ; Stomach Neoplasms - epidemiology ; Stomach Neoplasms - genetics ; Stomach Neoplasms - metabolism ; Stomach Neoplasms - pathology</subject><ispartof>Anticancer research, 2014-10, Vol.34 (10), p.5381-5388</ispartof><rights>Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25275032$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dauksa, Albertas</creatorcontrib><creatorcontrib>Gulbinas, Antanas</creatorcontrib><creatorcontrib>Endzinas, Zilvinas</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>El-Maarri, Osman</creatorcontrib><title>DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Recently, a set of studies addressed the question of the prevalence of aberrant methylation in surrogate tissues, such as peripheral blood leukocytes. Toward this aim, we conducted a case-control pilot study to investigate aberrant methylation in leukocytes of gastric cancer patients. The SNuPE combined with ion pair reverse phase HPLC (SIRPH method) was used to examine site-specific methylation status at selected CpG sites of the promoter regions of APC, ACIN1, BCL2, CD44, DAPK1, CDKN2A, RARB, TNFRSF10C HS3ST2 and of LINE-1, Alu repeats. We observed that in the patients, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while DNA repetitive elements were slightly less methylated compared to controls. This was found to be significantly associated with higher prevalence for gastric cancer. These results suggest that larger studies must be carried-out to explore the biological significance and clinical usefulness of leukocyte DNA as non-invasive detection tool for gastric cancer.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Case-Control Studies</subject><subject>Cluster Analysis</subject><subject>CpG Islands</subject><subject>DNA Methylation</subject><subject>Epigenesis, Genetic</subject><subject>Epigenomics</subject><subject>Female</subject><subject>Gene Expression Profiling</subject><subject>Humans</subject><subject>Leukocytes - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Staging</subject><subject>Prevalence</subject><subject>Repetitive Sequences, Nucleic Acid</subject><subject>Stomach Neoplasms - epidemiology</subject><subject>Stomach Neoplasms - genetics</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Stomach Neoplasms - pathology</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkL1OwzAYRS0EoqXwCsgjSyT_OxmrAgWpggXmyLE_U4PTBNtB6ttTQZkZrs5wj-5wT9Cc6oZWWnJyiuaESVJpQuQMXeT8TohSTc3P0YxJpiXhbI7c7dMS91C2-2hKGHbYFJwhgi3g8Gpc4xwKZBx2eIQUxi0kE3EXh8HhCNPHYPc_dcZjAhdsCV-AB4_fTC4pWGzNzkK6RGfexAxXRy7Q6_3dy-qh2jyvH1fLTTUyIUrlOkFBdA60ctJyo2pqiCCHKICmVh011GtCO0etENJo7wU0XlPPfO0M4wt087s7puFzglzaPmQLMZodDFNuqda8Zkoz_r8qa0WaRnF5UK-P6tT14Noxhd6kfft3Iv8G711vYw</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Dauksa, Albertas</creator><creator>Gulbinas, Antanas</creator><creator>Endzinas, Zilvinas</creator><creator>Oldenburg, Johannes</creator><creator>El-Maarri, Osman</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope></search><sort><creationdate>201410</creationdate><title>DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer</title><author>Dauksa, Albertas ; Gulbinas, Antanas ; Endzinas, Zilvinas ; Oldenburg, Johannes ; El-Maarri, Osman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p244t-db41e4bde76d5c3a681a040a046ee986b1a1f701bd1c445a7ff4e9f71f2f8da23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Case-Control Studies</topic><topic>Cluster Analysis</topic><topic>CpG Islands</topic><topic>DNA Methylation</topic><topic>Epigenesis, Genetic</topic><topic>Epigenomics</topic><topic>Female</topic><topic>Gene Expression Profiling</topic><topic>Humans</topic><topic>Leukocytes - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Staging</topic><topic>Prevalence</topic><topic>Repetitive Sequences, Nucleic Acid</topic><topic>Stomach Neoplasms - epidemiology</topic><topic>Stomach Neoplasms - genetics</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Stomach Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dauksa, Albertas</creatorcontrib><creatorcontrib>Gulbinas, Antanas</creatorcontrib><creatorcontrib>Endzinas, Zilvinas</creatorcontrib><creatorcontrib>Oldenburg, Johannes</creatorcontrib><creatorcontrib>El-Maarri, Osman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dauksa, Albertas</au><au>Gulbinas, Antanas</au><au>Endzinas, Zilvinas</au><au>Oldenburg, Johannes</au><au>El-Maarri, Osman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2014-10</date><risdate>2014</risdate><volume>34</volume><issue>10</issue><spage>5381</spage><epage>5388</epage><pages>5381-5388</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Recently, a set of studies addressed the question of the prevalence of aberrant methylation in surrogate tissues, such as peripheral blood leukocytes. Toward this aim, we conducted a case-control pilot study to investigate aberrant methylation in leukocytes of gastric cancer patients. The SNuPE combined with ion pair reverse phase HPLC (SIRPH method) was used to examine site-specific methylation status at selected CpG sites of the promoter regions of APC, ACIN1, BCL2, CD44, DAPK1, CDKN2A, RARB, TNFRSF10C HS3ST2 and of LINE-1, Alu repeats. We observed that in the patients, tumor suppressor genes were slightly but significantly higher methylated at several CpG sites, while DNA repetitive elements were slightly less methylated compared to controls. This was found to be significantly associated with higher prevalence for gastric cancer. These results suggest that larger studies must be carried-out to explore the biological significance and clinical usefulness of leukocyte DNA as non-invasive detection tool for gastric cancer.</abstract><cop>Greece</cop><pmid>25275032</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0250-7005
ispartof Anticancer research, 2014-10, Vol.34 (10), p.5381-5388
issn 0250-7005
1791-7530
language eng
recordid cdi_proquest_miscellaneous_1773826723
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Aged
Aged, 80 and over
Case-Control Studies
Cluster Analysis
CpG Islands
DNA Methylation
Epigenesis, Genetic
Epigenomics
Female
Gene Expression Profiling
Humans
Leukocytes - metabolism
Male
Middle Aged
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Staging
Prevalence
Repetitive Sequences, Nucleic Acid
Stomach Neoplasms - epidemiology
Stomach Neoplasms - genetics
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
title DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T08%3A47%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNA%20methylation%20at%20selected%20CpG%20sites%20in%20peripheral%20blood%20leukocytes%20is%20predictive%20of%20gastric%20cancer&rft.jtitle=Anticancer%20research&rft.au=Dauksa,%20Albertas&rft.date=2014-10&rft.volume=34&rft.issue=10&rft.spage=5381&rft.epage=5388&rft.pages=5381-5388&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1773826723%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1586099635&rft_id=info:pmid/25275032&rfr_iscdi=true